Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Niagen Bioscience (NAGE) EPS (Basic) (2016 - 2025)

Niagen Bioscience (NAGE) has disclosed EPS (Basic) for 15 consecutive years, with $0.05 as the latest value for Q4 2025.

  • On a quarterly basis, EPS (Basic) fell 44.44% to $0.05 in Q4 2025 year-over-year; TTM through Dec 2025 was $0.22, a 100.0% increase, with the full-year FY2025 number at $0.22, up 100.0% from a year prior.
  • EPS (Basic) was $0.05 for Q4 2025 at Niagen Bioscience, down from $0.06 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $0.09 in Q4 2024 to a low of -$0.13 in Q3 2021.
  • A 5-year average of -$0.02 and a median of -$0.01 in 2022 define the central range for EPS (Basic).
  • Peak YoY movement for EPS (Basic): plummeted 85.71% in 2021, then skyrocketed 20249.07% in 2025.
  • Niagen Bioscience's EPS (Basic) stood at -$0.07 in 2021, then soared by 71.43% to -$0.02 in 2022, then soared by 107.6% to $0.0 in 2023, then soared by 5819.87% to $0.09 in 2024, then plummeted by 44.44% to $0.05 in 2025.
  • Per Business Quant, the three most recent readings for NAGE's EPS (Basic) are $0.05 (Q4 2025), $0.06 (Q3 2025), and $0.04 (Q2 2025).